Global Genomic Medicine Consortium (G2MC)
Creating a community of global leaders dedicated to advancing genomic medicine implementation in clinical care.
We aim to accelerate the integration of impact health tools, technologies, and knowledge into diverse global health care systems.
It is our mission to forge cohort connections that revolutionize population health science by providing sustainable data infrastructure, cultivating a collaborative research environment, and promoting policies and best practices that foster connectivity, interoperability, and reciprocity.
7th G2MC International Conference, 2023
We are excited to share that the Global Genomic Medicine Consortium (G2MC) 7th International Conference will be held October 2-4, 2023 in Geneva, Switzerland. For those unable to attend in person, we will also be incorporating virtual sessions.
HOW WE WORK
Connect and Collaborate. Create Implementation Opportunities. Contribute to Demonstration Projects.
Our community is comprised of health professionals, scientists, educators, and policy makers in over 35 countries. We collaborate to demonstrate the value and the effective use of genomics in medicine. Join us to share and learn best practices.
LATEST NEWS & EVENTS
Our fourth and final day is done. We are so grateful to every presenter, attendee, and everyone behind the scenes making every aspect of #ICS5 work so well. The ideas discussed are going to do so much going forward, and we sincerely hope ICS6 is an in-person one! THANK YOU! https://t.co/8S81NLmFg2Read More
🧬PROJECT UPDATE🧬 Our Flagship Project Pilot Project is aiming to establish access to evidence-based exome sequencing for the diagnosis of rare uncharacterized and undiagnosed diseases. Read our progress here-> @CharitableRTW @CharitableRTW #rarediseases https://t.co/jHcrCmcMUNRead More
The FOURTH and FINAL Day of #ICS5 is set to begin! #genomics #webinar https://t.co/m5ae4qStd6Read More
Day Three HAS WRAPPED! An enormous thank you to Rongling Li for her closing remarks, and to all our incredible presenters! Tomorrow is the FINAL DAY, so get ready with our agenda here-> #ICS5 #genomics #webinar https://t.co/RR9lQnYtGrRead More
Day Three of #ICS5 is set to start w/ Sanjay Juvekar, Professor and Head Vadu Rural Health Program. ( @kemvadu ) Theme: Challenges, Best Practices, and Lessons Learned from LMIC/LRS #genomics #webinar https://t.co/AXxwrJRyfXRead More
Day Two is in the books! Thank you so much to Melanie Courtot (@mcourtot) for her Closing Remarks and to our amazing Presenters! We're half way done with #ICS5, see you all again tomorrow for Day Three! #genomics #webinar https://t.co/teqqCUvplwRead More
Scientists for Fair Publication Practices (#SfFPP) was founded in 2022 by 4 scientists, including Juergen Reichardt, a member of our Steering Committee, to address issues in Scientific Publications. For more on this initiative-👇 #genomics #fairpractice https://t.co/HrdsqLfhgnRead More
T-minus 10 minutes! Welcome + Keynote Introduction from IHCC Co-chair Peter Goodhand and Madeleine Thomson ( @madthomson ) Head of Climate Impacts & Adaptation, #Wellcome Trust! Full Agenda➡️ ➡️ #ICS5 @wellcometrust https://t.co/SKVqieu3PsRead More
And that's a wrap!! (for today) Thank you all for such an excellent Day One of #ICS5! See you same time tomorrow for Day Two! Check out the link for tomorrows agenda 👉 #Genomics #Webinar https://t.co/aXsfKlKCOwRead More
#ICS5 starts TOMORROW at 13UTC/8AM EST! We will be live tweeting EVERY Seminar (@IHCCGlobal). To find any and all info on the talk, or you'd just like to share your experience, be sure to use the #ICS5 hashtag! Full Agenda here!-> #Genomics #Webinar https://t.co/leUd7cYb2QRead More
Making an Impact
G2MC is an independent not-for-profit 501(c)(3) tax-exempt organization. Our mission to improve global health through the implementation of genomic tools and knowledge into health care delivery can only be advanced through the support of our sponsors and funders. Click below for more information on becoming a sponsor or providing a donation, including sponsorship benefit levels.